{"id":514397,"date":"2021-07-19T08:03:38","date_gmt":"2021-07-19T12:03:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-to-participate-in-two-july-investment-conferences\/"},"modified":"2021-07-19T08:03:38","modified_gmt":"2021-07-19T12:03:38","slug":"biocept-to-participate-in-two-july-investment-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-to-participate-in-two-july-investment-conferences\/","title":{"rendered":"Biocept to Participate in Two July Investment Conferences"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Biocept to Participate in Two July Investment Conferences<\/b><\/p>\n<p>SAN DIEGO&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.biocept.com&amp;esheet=52461670&amp;newsitemid=20210719005137&amp;lan=en-US&amp;anchor=Biocept%2C+Inc&amp;index=1&amp;md5=d55870ea6a72dec2456edbd0c38881a3\">Biocept, Inc<\/a>. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that Michael Nall, President and CEO, will participate at the following investment conferences:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li><b>Brookline Capital Markets Newport Symposium<\/b>, \u201c<i>Transformative Biotech \u2013 Cancer, Rare Diseases, and Viruses<\/i>,\u201d which will feature group and one-on-one investor meetings and panel discussions with scientific and industry experts. The conference is being held in Newport, R.I. on July 26.\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b>A.G.P.\u2019s Virtual MedTech Summer Conference<\/b>, which will feature one-on-one investor meetings. The conference is being held on July 29.\n<\/li>\n<\/ul>\n<p>\nThe Biocept Investor Presentation is available <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.biocept.com%2F&amp;esheet=52461670&amp;newsitemid=20210719005137&amp;lan=en-US&amp;anchor=here&amp;index=2&amp;md5=2ae5cefa1c891a0891448da88cd3907e\">here<\/a>.\n<\/p>\n<p><b>About Biocept<\/b><\/p>\n<p>\nBiocept, Inc. develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. In addition to its broad portfolio of blood-based liquid biopsy assays, Biocept has developed the CNSide\u2122 cerebrospinal fluid (CSF) assay that detects cancer that has metastasized to the central nervous system. Biocept\u2019s patented Target Selector\u2122 technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. Biocept also is leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic. For more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.biocept.com&amp;esheet=52461670&amp;newsitemid=20210719005137&amp;lan=en-US&amp;anchor=www.biocept.com&amp;index=3&amp;md5=7a188c2c34c66724b15400ff9f467a2f\">www.biocept.com<\/a>. Follow Biocept on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2Fbiocept%2F&amp;esheet=52461670&amp;newsitemid=20210719005137&amp;lan=en-US&amp;anchor=Facebook&amp;index=4&amp;md5=b99780226fa6ec5218b9a55c373e8451\">Facebook<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fbiocept%2F&amp;esheet=52461670&amp;newsitemid=20210719005137&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=5&amp;md5=a6e5841bfe7f2b7cb0fab64a10070e82\">LinkedIn<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FBiocept&amp;esheet=52461670&amp;newsitemid=20210719005137&amp;lan=en-US&amp;anchor=Twitter&amp;index=6&amp;md5=9b05899cb7226825d30920540f4035a9\">Twitter<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210719005137r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210719005137\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210719005137\/en\/<\/a><\/span><\/p>\n<p><b>Investor Contact:<br \/>\n<\/b><br \/>Jody Cain, LHA Investor Relations<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:Jcain@lhai.com\">Jcain@lhai.com<\/a>, 310-691-7100<\/p>\n<p><b><span class=\"bwuline\">Media Contact:<br \/>\n<\/span><\/b><br \/>Sampson PR Group<br \/>\n<br \/>Andrea Sampson<br \/>\n<br \/><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fasampson%40sampsonprgroup.com&amp;esheet=52461670&amp;newsitemid=20210719005137&amp;lan=en-US&amp;anchor=asampson%40sampsonprgroup.com&amp;index=7&amp;md5=4eda7a68188ff41cda8d51c5e680d7a0\">asampson@sampsonprgroup.com<\/a>, (562) 304-0301\n<\/p>\n<p><b>KEYWORDS:<\/b> United States North America California<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Medical Supplies Health Hospitals General Health Pharmaceutical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>Biocept to Participate in Two July Investment Conferences SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that Michael Nall, President and CEO, will participate at the following investment conferences: Brookline Capital Markets Newport Symposium, \u201cTransformative Biotech \u2013 Cancer, Rare Diseases, and Viruses,\u201d which will feature group and one-on-one investor meetings and panel discussions with scientific and industry experts. The conference is being held in Newport, R.I. on July 26. A.G.P.\u2019s Virtual MedTech Summer Conference, which will feature one-on-one investor meetings. The conference is being held on July 29. The Biocept Investor Presentation is available here. About Biocept Biocept, Inc. develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-to-participate-in-two-july-investment-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Biocept to Participate in Two July Investment Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-514397","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Biocept to Participate in Two July Investment Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-to-participate-in-two-july-investment-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biocept to Participate in Two July Investment Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Biocept to Participate in Two July Investment Conferences SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that Michael Nall, President and CEO, will participate at the following investment conferences: Brookline Capital Markets Newport Symposium, \u201cTransformative Biotech \u2013 Cancer, Rare Diseases, and Viruses,\u201d which will feature group and one-on-one investor meetings and panel discussions with scientific and industry experts. The conference is being held in Newport, R.I. on July 26. A.G.P.\u2019s Virtual MedTech Summer Conference, which will feature one-on-one investor meetings. The conference is being held on July 29. The Biocept Investor Presentation is available here. About Biocept Biocept, Inc. develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable &hellip; Continue reading &quot;Biocept to Participate in Two July Investment Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-to-participate-in-two-july-investment-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-19T12:03:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210719005137r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-to-participate-in-two-july-investment-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-to-participate-in-two-july-investment-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Biocept to Participate in Two July Investment Conferences\",\"datePublished\":\"2021-07-19T12:03:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-to-participate-in-two-july-investment-conferences\\\/\"},\"wordCount\":289,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-to-participate-in-two-july-investment-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210719005137r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-to-participate-in-two-july-investment-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-to-participate-in-two-july-investment-conferences\\\/\",\"name\":\"Biocept to Participate in Two July Investment Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-to-participate-in-two-july-investment-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-to-participate-in-two-july-investment-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210719005137r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-07-19T12:03:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-to-participate-in-two-july-investment-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-to-participate-in-two-july-investment-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-to-participate-in-two-july-investment-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210719005137r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210719005137r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-to-participate-in-two-july-investment-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biocept to Participate in Two July Investment Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biocept to Participate in Two July Investment Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-to-participate-in-two-july-investment-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Biocept to Participate in Two July Investment Conferences - Market Newsdesk","og_description":"Biocept to Participate in Two July Investment Conferences SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that Michael Nall, President and CEO, will participate at the following investment conferences: Brookline Capital Markets Newport Symposium, \u201cTransformative Biotech \u2013 Cancer, Rare Diseases, and Viruses,\u201d which will feature group and one-on-one investor meetings and panel discussions with scientific and industry experts. The conference is being held in Newport, R.I. on July 26. A.G.P.\u2019s Virtual MedTech Summer Conference, which will feature one-on-one investor meetings. The conference is being held on July 29. The Biocept Investor Presentation is available here. About Biocept Biocept, Inc. develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable &hellip; Continue reading \"Biocept to Participate in Two July Investment Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-to-participate-in-two-july-investment-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-19T12:03:38+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210719005137r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-to-participate-in-two-july-investment-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-to-participate-in-two-july-investment-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Biocept to Participate in Two July Investment Conferences","datePublished":"2021-07-19T12:03:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-to-participate-in-two-july-investment-conferences\/"},"wordCount":289,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-to-participate-in-two-july-investment-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210719005137r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-to-participate-in-two-july-investment-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-to-participate-in-two-july-investment-conferences\/","name":"Biocept to Participate in Two July Investment Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-to-participate-in-two-july-investment-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-to-participate-in-two-july-investment-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210719005137r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-07-19T12:03:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-to-participate-in-two-july-investment-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biocept-to-participate-in-two-july-investment-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-to-participate-in-two-july-investment-conferences\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210719005137r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210719005137r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-to-participate-in-two-july-investment-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Biocept to Participate in Two July Investment Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/514397","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=514397"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/514397\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=514397"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=514397"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=514397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}